CD-Chex CD103 Plus® by Streck
Manufacturer Streck | Available Worldwide
CD-Chex CD103 Plus is a positive flow cytometry control for CD103, CD30, CD38, CD56, CD138 and cytoplasmic Lambda expression.
CD-Chex CD103 Plus®
CD-Chex CD103 Plus is a ready-to-use control for evaluating CD103, CD30, CD38, CD56, CD138 and cytoplasmic Lambda expression by flow cytometry. This control provides assay values for two distinct abnormal leukocyte populations: CD45+ and CD45-. The CD45+ abnormal lymphocyte population contains multiple markers designated as “rare flow antigens” by CAP, including CD30 and CD103.
CD-Chex CD103 is designed to monitor reagent staining, erythrocyte lysis, sample preparation and instrument performance and is compatible with BD® Biosciences and Beckman Coulter® flow cytometry systems.
Features
- Only commercially available control assayed for CD103, CD30, CD38, CD56, CD138 and cytoplasmic Lambda
- Two distinct abnormal leukocyte populations: CD45+ and CD45-
- Compatible with BD Biosciences and Beckman Coulter flow cytometry systems
- 30-day open-vial stability; 90-day closed-vial stability
Benefits
- Helps clinical laboratories meet quality requirements for leukemia and lymphoma immunophenotyping
- Manufacturer established assay ranges – no need to verify range per CAP requirements
- Eliminates the need for labs to hold and validate patient samples for use as a control
- Access to STATS®, Streck’s free interlaboratory quality control program for peer group data comparison
- For Research Use Only. Not for use in diagnostic procedures.
Product Overview
